Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Gil, C. Medina, L. Fernández, F. J. Martínez, C. Corona, P. A. Chinchurreta, J. R. Siles, F. Torres, F. Ruiz (Marbella, Spain). Clinical characteristics of the pulmonary hypertension (PH) in a cardiologist service. Eur Respir J 2011; 38: Suppl. 55, 2337

Member's Comments

No comment yet.

Related content which might interest you: An evaluation of outcomes for patients with pulmonary hypertension (PH) incorporated into a standard UK pulmonary rehabilitation (PR) programme Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Cambridge pulmonary hypertension outcomes review (CAMPHOR) utility assessment in pulmonary hypertension (PH) patients Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Clinical sildenafil use in Belgian patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Clinical features of pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical features of pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Clinical features of pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Impact of pulmonary hypertension (PH) on healthcare resource utilization and costs in patients with portal hypertension Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients Source: Eur Respir J 2007; 30: Suppl. 51, 343s Year: 2007 Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010 Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH? Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety. Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Smoking history and pulmonary arterial hypertension (PAH) onset and clinical outcomes (REVEAL) Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Optimising the management of pulmonary arterial hypertension patients: emergency treatments Source: Eur Respir Rev 2010 19: 204-211 Year: 2010 Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018